SecBot SecBot
DEFA14A ·Filed May 26, 2026

KAPA

Kairos Pharma, LTD.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001493152-26-025287
Proxy solicitation materials
Actionable Insight • Neutral

No trading action warranted. The correction is administrative and does not affect the meeting's substance or voting mechanics. Monitor for any subsequent activist or dissident filings ahead of the June 29 meeting.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
KAPA ▼ -42.92% at T+60d
NEUTRAL call -42.92% · α vs SPY -44.80% · entry $0.5170 → $0.2951
Entry = T+0 close
May 26, 2026
via day close
T+1d
+1.93%
call +1.93% · α +1.38%
$0.5270
settled 5mo ago
T+5d
-10.64%
call -10.64% · α -11.11%
$0.4620
settled 5mo ago
T+20d
-27.50%
call -27.50% · α -25.60%
$0.3748
settled 4mo ago
T+60d
-42.92%
call -42.92% · α -44.80%
$0.2951
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Kairos Pharma filed a DEFA14A supplement correcting the record date for its 2026 Annual Meeting from May 15 to May 18, 2026. This is a routine administrative correction with no material impact on the meeting or shareholder voting.

Key Financial Metrics

Meeting
2026-06-29

Key Facts

  • Corrected record date for 2026 Annual Meeting is May 18, 2026 (previously stated as May 15, 2026).
  • Annual Meeting scheduled for June 29, 2026, at 9:00 a.m. PDT / 12:00 p.m. EDT, held virtually.
  • Only stockholders of record as of May 18, 2026 are entitled to vote.
  • No other changes to the proxy statement.

Financial Impact

No financial impact — administrative correction only.

Risk Factors

  • None from this filing; no material risk identified.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-025287
Document: 0001493152-26-025287-index-headers.html0001493152-26-025287
Document: 0001493152-26-025287-index.html0001493152-26-025287
Document: 0001493152-26-025287.txt0001493152-26-025287
6 reports for KAPA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for KAPA — sortable, filterable
TypeNow
Oct 6, 2026
21d ago
8-K
BULLISH ★ 6/10
$1.15 $0.8287▼ −27.94%▼ −27.80%$0.5300 (−53.91%)
Jul 22, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$0.3127 $0.2990▼ −4.38%▼ −1.98%$0.5300 (+69.49%)
Jul 15, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$0.3180 $0.3127▼ −1.67%▼ −0.69%$0.5300 (+66.67%)
Jun 4, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$0.4660 $0.4580▼ −1.72%▲ +0.84%$0.5300 (+13.73%)
May 26, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$0.5170 $0.4620▼ −10.64%▼ −11.11%$0.5300 (+2.51%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 7/10
$0.5520 $0.6560▲ +18.84%▲ +19.97%$0.5300 (−3.99%)
Showing 6 of 6

US Market Status

Market Closed — Opens Thu (10h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026